Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | revenue | rating |
---|---|---|---|---|---|---|---|
Applied Therapeutics, Inc. | $4.38 | $533.63 M | -2.45 | 26 | $9.99 M | ||
C4 Therapeutics, Inc. | $4.55 | $320.64 M | -1.97 | 145 | $20.76 M | ||
Cidara Therapeutics, Inc. | $12.16 | $58.57 M | -1.59 | 69 | $63.91 M | ||
Cerevel Therapeutics Holdings, Inc. | $40.30 | $7.29 B | -14.66 | 355 | $0 | ||
Cullinan Oncology, Inc. | $16.78 | $1.29 B | -7.16 | 85 | $0 | ||
Centessa Pharmaceuticals plc | $8.58 | $884.24 M | -6.2 | 77 | $6.88 M | ||
CytomX Therapeutics, Inc. | $1.30 | $127.79 M | 7.81 | 120 | $101.21 M | ||
Eliem Therapeutics, Inc. | $6.86 | $258.33 M | -17.08 | 9 | $0 | ||
Monte Rosa Therapeutics, Inc. | $3.89 | $243.38 M | -1.59 | 130 | $0 | ||
Genfit S.A. | $3.98 | $269.95 M | -8.62 | 159 | $28.57 M | ||
IGM Biosciences, Inc. | $6.45 | $485.17 M | -1.95 | 216 | $2.13 M | ||
Mineralys Therapeutics, Inc. | $12.15 | $652.38 M | -6.03 | 28 | $0 | ||
Nuvalent, Inc. | $72.05 | $5.11 B | -32.72 | 106 | $0 | ||
Opthea Limited | $1.91 | $214.34 M | -1.04 | 24 | $108,406 | ||
Prelude Therapeutics Incorporated | $3.62 | $205.99 M | -2.02 | 128 | $0 | ||
Avidity Biosciences, Inc. | $37.21 | $2.54 B | -8.99 | 253 | $9.56 M | ||
Shattuck Labs, Inc. | $3.70 | $333.81 M | -3.64 | 75 | $1.66 M | ||
Tarsus Pharmaceuticals, Inc. | $28.93 | $1.22 B | -6.78 | 244 | $17.45 M |